Pharmaceuticals

Global Anti-D Immunoglobulin Industry Trends and Market Forecast 2026–2030

February 12, 2026February 12, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the anti-d immunoglobulin market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Anti-D Immunoglobulin Market?

The anti-d immunoglobulin market size has demonstrated significant expansion in recent years. It is projected to climb from $2.59 billion in 2025 to $2.76 billion in 2026, reflecting a compound annual growth rate (CAGR) of 6.6%. The market’s historical growth can be attributed to factors like restricted plasma donor availability, dependence on manual antibody extraction processes, heightened awareness of hemolytic disease, increased utilization in hospitals and clinics, and the shift towards intramuscular administration.

The anti-d immunoglobulin market is projected to experience substantial expansion over the upcoming years, reaching a valuation of $3.55 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.5%. This projected growth throughout the forecast period stems from factors such as advancements in intravenous formulations, the proliferation of automated plasma fractionation technologies, an increase in antenatal screening initiatives, improvements in the worldwide blood bank infrastructure, and the expansion of personalized immunoglobulin therapies. Key trends anticipated during this period encompass a heightened need for anti-d immunoglobulin in managing hemolytic disease, a greater uptake of pre-filled syringes and single-use vials, the broadening of antenatal and postnatal prophylaxis programs, an increase in distribution through hospital and blood bank networks, and a reinforced emphasis on ensuring safety, purity, and adherence to regulations.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25694&type=smp

Which Drivers Are Supporting The Rise Of The Anti-D Immunoglobulin Market?

The high birth rates are projected to fuel the expansion of the anti-D immunoglobulin market. Birth rates signify the annual count of live births per 1,000 individuals within a population. These rates are rising due to insufficient access to education and family planning resources, leading to increased fertility and larger families. Anti-D immunoglobulin aids in managing birth rates by preventing Rh incompatibility during pregnancy, thereby lessening the risk of hemolytic disease in newborns and promoting healthier outcomes in subsequent pregnancies. For instance, in April 2025, the Centers for Disease Control and Prevention, a US government body, reported 3,622,673 births in 2024, marking a 1% increase from 2023. Consequently, elevated birth rates are stimulating growth in the anti-D immunoglobulin market. The anti-D immunoglobulin market is anticipated to grow with the ongoing expansion of healthcare infrastructure. Healthcare infrastructure encompasses the essential facilities, equipment, workforce, and support systems required for delivering medical services to a population. This infrastructure is expanding due to the increasing global population, which drives higher demand for healthcare and necessitates the development of more hospitals, clinics, and related resources. Such expansion improves access to maternal healthcare, facilitating better screening and the timely administration of anti-D immunoglobulin to prevent hemolytic disease in newborns. For example, in May 2023, the UK’s Department of Health and Social Care announced plans to invest over $27 billion (£20 billion) in new hospital facilities. Under the New Hospital Programme, two hospitals have been completed, five are under construction, and more than 20 are expected to be initiated or finalized by the close of 2023. Therefore, the expanding healthcare infrastructure is a key driver for the anti-D immunoglobulin market.

What Segments Are Identified Within The Structure Of The Anti-D Immunoglobulin Market?

The anti-d immunoglobulin market covered in this report is segmented –

1) By Product Type: Intramuscular Anti-D Immunoglobulin, Intravenous Anti-D Immunoglobulin

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channel

3) By Application: Hemolytic Disease Of The Newborn, Immune Thrombocytopenic Purpura, Antenatal And Postnatal Prophylaxis, Other Applications

4) By End-User: Hospitals, Clinics, Blood Banks, Research Laboratories

Subsegments:

1) By Intramuscular Anti-D Immunoglobulin: Standard Dose, High Dose, Pre-Filled Syringes, Vials

2) By Intravenous Anti-D Immunoglobulin: Lyophilized Powder, Liquid Formulation, Single-Use Vials, Multi-Dose Vials

Which Key Market Players Are Investing In Expansion And Innovation Within The Anti-D Immunoglobulin Market?

Major companies operating in the anti-d immunoglobulin market are CSL Behring, Octapharma AG, Kedrion Biopharma Inc., Biotest AG, Sanquin, Bharat Serums and Vaccines Limited, Intas Pharmaceuticals Ltd., Zydus Lifesciences Limited, Emergent BioSolutions Inc., Kamada Pharmaceuticals, Saol Therapeutics Inc., Avin Darou, Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., Taj Pharmaceuticals Limited, Aetos Pharma Private Limited, PV Pharma Healthcare Pvt. Ltd., Grifols S.A., Takeda Pharmaceutical Company Limited, LFB Biomedicaments, China Biologic Products Holdings Inc., Shanghai RAAS Blood Products Co. Ltd., Hualan Biological Engineering Inc., CBPO (Shandong Taibang Biological Products Co. Ltd.), Bio Products Laboratory (BPL), Instituto Grifols S.A., HemaCare Corporation, KM Biologics Co. Ltd., National Bioproducts Institute (NBI), GC Pharma (Green Cross Corporation), SK Plasma Co. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/anti-d-immunoglobulin-global-market-report

Which Regions Are Poised For Strategic Growth In The Anti-D Immunoglobulin Market?

North America was the largest region in the anti-D immunoglobulin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-d immunoglobulin market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Anti-D Immunoglobulin Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25694&type=smp

Browse Through More Reports Similar to the Global Anti-D Immunoglobulin Market 2026, By The Business Research Company

Immunoglobulins Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report

Intravenous Immunoglobulin Market Report 2026

https://www.thebusinessresearchcompany.com/report/intravenous-immunoglobulin-global-market-report

Immunoassay Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795